CCL2 and atherosclerosis: In a low-grade inflammation state, such as established atherosclerosis, E2 can destabilize atherosclerotic plaques by inducing molecules like MCP-1 and matrix metalloproteinases (specifically MMP-2 and MMP-9) in endothelial cells [32].